2001 consensus guidelines for the management of women with cervical cytological abnormalities

JAMA

Volumn 287, Issue 16, 2002, Pages 2120-2129

  Wright, Thomas C ^a   Thomas Cox, J ^b   Stewart Massad, L ^c   Twiggs, Leo B ^d   Wilkinson, Edward J ^e  

^a Surgeons of Columbia University ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Jr Hospital of Cook County   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOMA IN SITU; COLPOSCOPY; DNA DETERMINATION; HUMAN; INTERNET; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; SQUAMOUS CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

EID: 0037165728     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.16.2120     Document Type: Article

References (89)

1. The Bethesda System
2. Quality management in gynecologic cytology using interlaboratory comparison
3. The 2001 Bethesda System: Terminology for reporting results of cervical cytology
4. Identifying women with cervical neoplasia
5. Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears
6. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
7. Guide to development of practice guidelines
8. The "ASCUS" swamp
9. Toward objective quality assurance in cervical cytopathology
10. Interobserver reproducibility of cervical cytologic and histologic interpretations
11. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance
12. Should all women with cervical atypia be referred for colposcopy: A HARNET study
13. Incidence and predictors of cervical dysplasia in patients with minimally abnormal Papanicolaou smears
14. Cervicography combined with repeat Papanicolaou test as triage for low-grade cytologic abnormalities
15. Subclassifying atypical squamous cells in Thin-Prep cervical cytology correlates with detection of high-risk human papillomavirus DNA
16. The "Inconclusive-possible high grade epithelial abnormality" category in Papanicolaou smear reporting
17. Do qualifiers of ASCUS distinguish between low- and high-risk patients?
18. Qualification of ASCUS: A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study (ALTS)
19. Atypical squamous metaplastic cells
20. Follow-up of abnormal gynecologic cytology: A college of American pathologists Q-probes study of 16132 cases from 306 laboratories
21. The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytologic results
22. Clinical significance of mild cytologic atypia on Papanicolaou smears from women infected with human immunodeficiency virus
23. Human papillomavirus infection in HIV-seropositive women
24. Significance of a diagnosis of atypical squamous cells of undetermined significance for Papanicolaou smears in perimenopausal and postmenopausal women
25. Diagnosis of "ASCUS" in women over age 50 is less likely to be associated with dysplasia
26. Human papillomavirus testing in women with mild cytologic atypia
27. Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL
28. High-risk HPV DNA detection by Hybrid Capture II
29. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears
30. Interim guidelines for management of abnormal cervical cytology
31. Management guidelines for the follow-up of atypical squamous cells of undetermined significance (ASCUS)
32. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance
33. Triage of women with ASCUS and LSIL on Pap smear reports
34. Colposcopy for the diagnosis of squamous intraepithelial lesions: A metaanalysis
35. Effects of age and human papilloma viral load on colposcopy triage
36. Atypical glandular cells of undetermined significance (AGUS)
37. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening
38. Incidence and evaluation of an AGUS Papanicolaou smear in primary care
39. Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology
40. Atypical cervical cytology: Colposcopic follow-up using the Bethesda System
41. Endocervical glandular atypia in Papanicolaou smears
42. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology
43. Atypical glandular cells of undetermined significance
44. Papanicolaou smears by the Bethesda system in endometrial malignancy
45. Atypical glandular cells of undetermined significance
46. Clinical significance of atypical glandular cells of undetermined significance in postmenopausal women
47. The reliability of a cytological prediction of cervical adenocarcinoma in situ
48. Atypical endocervical glandular cells: Accuracy of cytologic diagnosis
49. Cervical cytology reported as negative and risk of adenocarcinoma of the cervix
50. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal pap smears
51. Papanicolaou smear sensitivity for adenocarcinoma in situ of the cervix: A study of 34 cases
52. Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: A study of 49 cases
53. A prospective study of conization of the cervix in the management of cervical intraepithelial glandular neoplasia (CIGN): A preliminary report
54. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix
55. Adenocarcinoma in situ of the cervix
56. Where's the high-grade cervical neoplasia?
57. Clinical evaluation of atypical glandular cells of undetermined significance
58. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population
59. Adenocarcinoma in situ of the uterine cervix: An experience with 100 cases
60. Adenocarcinoma in situ of the uterine cervix
61. Adenocarcinoma in situ of the uterine cervix
62. ASCCP Practice Guidelines: Management of glandular abnormalities in the cervical smear
63. Adenocarcinoma in situ of the cervix
64. Squamous intraepithelial lesions of the cervix in a high-risk population
65. Cytological changes preceding cervical cancer
66. Risk of cervical cancer associated with mild dyskaryosis
67. Conservative treatment of mild/moderate cervical dyskaryosis: Long-term outcome
68. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions
69. Colposcopic diagnosis and treatment of cervical dysplasia at a single clinic visit
70. Loop diathermy excision of the cevical transformation zone in patients with abnormal cervical smears
71. How can the incidence of negative specimens resulting from large loop excision of the cervical transformation zone (LLETZ) be reduced?
72. Indications for cone biopsy: Pathologic correlation
73. Biopsy correlates of abnormal cervical cytology classified using the Bethesda system
74. Cervical biopsy-cytology correlation: A College of American Pathologists Q-Probes study of 22 439 correlations in 348 laboratories
75. LSIL biopsies after HSIL smears
76. Histological differences between colposcopic-directed biopsy and loop excision of the transformation zone (LETZ)
77. A prospective follow up study of women with colposcopically unconfirmed positive cervical smears
78. Variance in the interpretation of cervical biopsy specimens obtained for atypical squamous cells of undetermined significance
79. Bethesda classification of cervicovaginal smears: Reproducibility and viral correlates
80. Colposcopic evaluation of abnormal Papanicolaou smears in pregnancy
81. Abnormal cervical cytology in pregnancy: A 17-year experience
82. Abnormal cervical cytology in pregnancy
83. Efficacy and safety of large-loop excision of the transformation zone
84. Does colposcopically directed punch biopsy reduce the incidence of negative LLETZ?
85. A single-visit cervical carcinoma prevention program offered at an inner city church: A pilot project
86. One-session management of cervical intraepithelial neoplasia
87. Purpose of quality standards for infectious diseases